Monte Rosa Therapeutics: Q4 Earnings Insights

Monte Rosa Therapeutics GLUE reported its Q4 earnings results on Thursday, March 14, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Monte Rosa Therapeutics missed estimated earnings by -76.0%, reporting an EPS of $-0.58 versus an estimate of $-0.33.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 3.0% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Monte Rosa Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.